The Independent questions 10,000 steps target

- The Independent reported on August 6 that the 10,000-steps-a-day target came from a 1965 Japanese pedometer brand, not laboratory research. - JAMA researchers found mortality benefits rose with higher daily steps but appeared to level off around 7,500 for older women, while cadence added less. - The Straits Times said on August 5 that brisker walking also matters; its column is available on the newspaper’s opinion section.

The Independent reported on August 6 that the familiar 10,000-steps-a-day target did not begin as a scientific threshold but as a marketing phrase tied to a Japanese pedometer sold in 1965. JAMA and NIH summaries of step-count research have made the same point, tracing the number to the “manpo-kei,” or “10,000 steps meter,” rather than to a laboratory standard. The newer evidence cited around that target points in a different direction. Large cohort studies have found that health benefits can appear well below 10,000 daily steps, even if higher totals remain associated with lower risk up to a point. The Straits Times wrote on August 5 that speed matters too, saying people should consider not only how far they walk but “how fast you walk.” (jamanetwork.com) ### Where did the 10,000-step target actually come from? A 1965 Japanese pedometer called the manpo-kei is the most widely cited origin of the 10,000-step benchmark. A JAMA commentary described the number as the likely product of that brand name, and a JAMA Internal Medicine study said the goal had “limited scientific basis” despite becoming a common public-health shorthand. (straitstimes.com) The Independent’s August 6 article echoed that history, arguing that the target’s cultural staying power has outlasted the evidence behind it. That framing aligns with NIH’s summary of later research, which said the often-cited 10,000-step goal has only limited support as a universal threshold. ### How many steps have studies linked to better health? A 2019 JAMA Internal Medicine study of older women found that women taking about 4,400 steps a day had lower mortality rates than those taking about 2,700, with benefits continuing to rise before leveling off at roughly 7,500 steps a day. (jamanetwork.com) The paper said it did not find that 10,000 steps was necessary to see lower risk. (irp.nih.gov) A 2022 JAMA Internal Medicine study using UK Biobank data from 78,500 adults also found lower risks for all-cause mortality and for cancer and cardiovascular disease outcomes at step counts below 10,000. That study reported that around 9,800 steps a day was associated with the lowest all-cause mortality risk, while about 8,800 was linked to the lowest incidence of cardiovascular disease. (jamanetwork.com) ### Does walking speed matter, or only the total number? The Straits Times said this week that intensity should be part of the conversation, not just the daily total. Its August 5 column said people may want to focus on “how hard you walk,” reflecting evidence that brisk walking can carry its own health signal. A 2020 JAMA study of U.S. adults found that taking more steps per day was associated with lower mortality, while step-intensity measures did not show a clear association after accounting for total steps. (jamanetwork.com) But the 2022 JAMA Internal Medicine study found that incidental steps — the quicker, less deliberate steps accumulated during daily life — were also associated with lower disease and mortality risk. (straitstimes.com) ### Why hasn’t the 10,000 number gone away? Fitness trackers and workplace wellness programs helped turn a round number into a durable target. NIH said step counts remain an easy way for people to measure activity, especially as phones and wearables track movement automatically. The research record has not replaced that simple benchmark with one single number for everyone. (pubmed.ncbi.nlm.nih.gov) Instead, the studies cited by JAMA, NIH and The Straits Times describe a dose-response pattern: more walking is generally linked to better outcomes, but meaningful gains can begin below 10,000 and may depend partly on pace and context. ### What should readers watch for next? (irp.nih.gov) The Straits Times’ August 5 opinion piece and The Independent’s August 6 article are the latest consumer-facing summaries of a research base that continues to grow. Future updates are likely to come from cohort studies and guideline reviews that compare total steps, walking cadence and disease-specific outcomes in different age groups. (straitstimes.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.